New York, NY -- (SBWIRE) -- 08/16/2017 -- Drug Eluting Balloons (DEBs) Market 2017

Executive Summary
A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).

The analysts forecast the global drug eluting balloons market to grow at a CAGR of 27.14% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global drug eluting balloons market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of DEBs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1482555-global-drug-eluting-balloons-debs-market-2017-2021

The report, Global Drug Eluting Balloons Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- B. Braun Melsungen
- Cook Medical
- C.R. Bard
- Eurocor
- Medtronic

Other prominent vendors
- Aachen Resonance
- Acrostak
- Cardionovum
- Spectranetics

Market driver
- Growing demand for cath labs
- For a full, detailed list, view our report

Market challenge
- Stringent regulatory process
- For a full, detailed list, view our report

Market trend
- Favorable reimbursement policies
- For a full, detailed list, view our report

Complete Report Details @ https://www.wiseguyreports.com/reports/1482555-global-drug-eluting-balloons-debs-market-2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- PADs
- CADs

PART 05: Market landscape
- Market overview
- Five forces analysis

PART 06: Market segmentation by product
- Peripheral DEBs
- Coronary DEBs

PART 07: Market segmentation by end-user
- Cath labs
- Hospitals
- Ambulatory surgery centers (ASCs)

PART 08: Geographical segmentation
- Drug eluting balloons market in EMEA
- DEBs market in Americas
- DEBs market in APAC

PART 09: Decision framework
PART 10: Drivers and challenges
- Market drivers
- Market challenges
PART 11: Market trends

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check:
https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check:
https://www.wiseguyreports.com/seminars